Sign In
Buy TNDM
$18.03
-0.570 (-3.06%)
At Close: Jun 03, 2026
Tandem Diabetes Care (NASDAQ:TNDM) Stock Price Up 9% Following Analyst Upgrade
01:32am, Tuesday, 24'th Feb 2026
Tandem Diabetes Care, Inc. (NASDAQ: TNDM - Get Free Report)'s share price rose 9% on Monday after Lake Street Capital upgraded the stock from a hold rating to a buy rating. Lake Street Capital now has
Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes
04:05pm, Monday, 23'rd Feb 2026
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, announced today that it intends to offer, subject to market conditions
Tandem Diabetes Care: Strong Q4 Execution Amid A PayGo Transition
11:58am, Monday, 23'rd Feb 2026
Tandem Diabetes Care, Inc. delivered strong Q4 '25 results, with revenue and gross margin beats driving a 32% stock surge. TNDM's shift to a pay-as-you-go model will temporarily compress reported reve
Why Tandem Diabetes Care Stock Popped Today
09:59pm, Friday, 20'th Feb 2026
Tandem saw robust demand for its insulin pumps in the fourth quarter. Management expects further shipment growth in 2026.
Tandem Diabetes Shares Rise 33% On Earnings Beat, Margin Expansion, Growth Outlook
01:01pm, Friday, 20'th Feb 2026
The stock is moving higher as the broader market is experiencing positive momentum, with the Nasdaq up 0.62% today, contributing to the bullish sentiment.
Tandem Diabetes Care Analysts Boost Their Forecasts After Upbeat Q4 Results
11:58am, Friday, 20'th Feb 2026
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) reported better-than-expected fourth-quarter financial results on Thursday.
TNDM Q4 Earnings & Revenues Beat Estimates, Gross Margin & Stock Up
10:16am, Friday, 20'th Feb 2026
Tandem Diabetes tops Q4 estimates with narrower loss, 15% revenue jump and wider gross margin, sending shares up 6.7% after hours.
Tandem Diabetes Care, Inc. (TNDM) Q4 2025 Earnings Call Transcript
02:24am, Friday, 20'th Feb 2026
Tandem Diabetes Care, Inc. (TNDM) Q4 2025 Earnings Call Transcript
Tandem Diabetes Care (TNDM) Reports Q4 Earnings: What Key Metrics Have to Say
07:00pm, Thursday, 19'th Feb 2026
While the top- and bottom-line numbers for Tandem Diabetes Care (TNDM) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key m
Tandem Diabetes Care, Inc. (TNDM) Reports Q4 Loss, Tops Revenue Estimates
06:21pm, Thursday, 19'th Feb 2026
Tandem Diabetes Care, Inc. (TNDM) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to a loss of $0.44 per share a year ago.
Tandem Diabetes Care Announces Fourth Quarter and Full Year 2025 Financial Results and 2026 Financial Guidance
04:05pm, Thursday, 19'th Feb 2026
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter and fiscal year e
Unlocking Q4 Potential of Tandem Diabetes Care (TNDM): Exploring Wall Street Estimates for Key Metrics
10:16am, Tuesday, 17'th Feb 2026
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Tandem Diabetes Care (TNDM), delve into some of its key metrics to gain a deeper insight into the company's potential performanc
Tandem Diabetes Care Announces Upcoming Conference Presentations
04:05pm, Thursday, 12'th Feb 2026
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the
NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes C
New York, New York--(Newsfile Corp. - February 10, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tan
